Additional Permitted Disclosures. Each Party and its Affiliates and its and their Sublicensees may disclose Confidential Information of the other Party as may be necessary or useful in connection with the Exploitation of the Licensed Compound, the Licensed Products (including in connection with any filing, application or request for Regulatory Approval by or on behalf of such Party or any of its Affiliates or its or their Sublicensees) or otherwise in connection with the performance of its obligations or exercise of such Party’s rights as contemplated by this Agreement, including to existing or potential Distributors, Sublicensees, collaboration partners or acquirers.
Appears in 4 contracts
Sources: Collaboration Agreement (Eikon Therapeutics, Inc.), Collaboration Agreement (Eikon Therapeutics, Inc.), Collaboration Agreement (Eikon Therapeutics, Inc.)